Advanced Infection Control — MDRO & Outbreak Management

🧬 Multi-Drug Resistant Organisms (MDROs)

Definition & Concept

MDRO: organism resistant to ≥1 agent in ≥3 antimicrobial categories
Extensively drug-resistant (XDR): susceptible to only 1–2 categories; Pandrug-resistant (PDR): no susceptible agents remain
Resistance arises through mutation, horizontal gene transfer, and selection pressure from antibiotic overuse
MDROs spread mainly via hands of healthcare workers — hand hygiene is the single most important intervention

WHO Priority Pathogens 2024

Critical

CRE (Carbapenem-resistant Enterobacterales — K. pneumoniae, E. coli) · CRAB (Carbapenem-resistant Acinetobacter baumannii) · CRPA (Carbapenem-resistant Pseudomonas aeruginosa)

High

MRSA (Methicillin-resistant Staphylococcus aureus) · VRE (Vancomycin-resistant Enterococcus) · Fluoroquinolone-resistant Salmonella · Third-generation cephalosporin-resistant E. coli / K. pneumoniae (ESBL)

Medium

Clarithromycin-resistant H. pylori · Fluoroquinolone-resistant Campylobacter · Fluoroquinolone-resistant N. gonorrhoeae · Penicillin-non-susceptible Streptococcus pneumoniae

GCC MDRO Burden

CRAB: very high prevalence in GCC ICUs — among the most common ICU pathogens in Saudi Arabia, UAE, Kuwait
ESBL-producing Klebsiella: widespread community and hospital acquisition across GCC
MRSA: rates lower in Gulf Arab nationals vs. expatriate workers (occupational exposure risk)
KPC (Klebsiella pneumoniae carbapenemase): emerging in GCC — historically New Delhi MBL (NDM) predominant
VRE: sporadic outbreaks reported in Saudi Arabia and UAE tertiary hospitals
High antibiotic use, medical tourism, large migrant workforce — major drivers of MDRO burden in GCC

Horizontal Gene Transfer — How Resistance Spreads

Plasmids: small circular DNA elements that carry resistance genes (e.g., NDM, KPC, OXA-48) — transferred between different bacterial species
Conjugation: direct cell-to-cell transfer of plasmids — most common and clinically important mechanism
Transduction: bacteriophage-mediated transfer of resistance genes (MRSA)
Transformation: uptake of free DNA from environment — less common
Clinical implication: a single patient colonised with a plasmid-carrying CRAB can seed an entire ICU within days without strict infection control
Integrons and transposons allow multiple resistance genes to be packaged on one plasmid — creates XDR organisms

MDRO Screening Policies — Who to Screen & How

Indications for Admission Screening:

Patients admitted from high-risk countries (South Asia, Middle East, Africa) — NDM, OXA-48
Long-term care facility (LTCF) residents / nursing home transfers
Prior known MDRO history — automatic re-screen
ICU admissions — active surveillance on entry
Patients with indwelling devices (catheter, PEG, tracheostomy)
Repatriation / medical evacuation cases

Culture Site Selection:

Rectal swab: most sensitive site for CRE and VRE — bowel colonisation precedes infection
Nasal swab (anterior nares): gold standard for MRSA — bilateral, rotate 5× each side
Groin / axilla swab: additional sites for MRSA in high-risk patients
Wound/ulcer swab: chronic wounds colonised with MDRO common
Urine (catheter): ESBL/CRE — catheterised patients at high risk
Throat swab: for CPE in select protocols

🧤 Contact Precautions & MRSA Decolonisation

Single Room Isolation

Mandatory for CRAB, CRE, MRSA, VRE — prioritise negative pressure rooms for CRAB if available
Door must remain closed — isolation door sign clearly displayed (standardised GCC signage)
Dedicated patient bathroom where possible — shared toilets require enhanced cleaning
PPE station outside room: gloves, gown, mask, eye protection
Patient and family information notice on door — include visitor instructions

Cohort Nursing

Used when single rooms are insufficient during outbreaks or high census periods
Cohort same organism/resistance pattern together — do NOT mix MRSA with CRAB
Assign dedicated nursing staff to cohort — do not rotate staff between cohort and non-cohort patients on same shift
Clear documentation of cohorting rationale in care plan and medical record
Cohort patients at same end of bay — never in central beds

PPE Sequence — Contact Precautions

Sequence is critical — errors cause self-contamination and healthcare-worker colonisation

DONNING (putting on) — before entering room:

1Hand Hygiene (gel)

›

2Gown (tie at back)

›

3Mask / Face Shield

›

4Gloves (over cuffs)

DOFFING (removing) — BEFORE leaving room:

1Remove Gloves (outer surface contaminated)

›

2Remove Gown (roll inside-out)

›

3Hand Hygiene (gel)

›

4Remove Mask / Eye Protection

›

5Hand Hygiene (gel)

Critical: Remove ALL PPE BEFORE leaving the room. Contaminated PPE worn in corridor = transmission event.

Dedicated Equipment — Patient-Specific

Stethoscope: stay in room, label with patient name — wipe with 70% IPA after each use
Blood pressure cuff: patient-dedicated — not shared — decontaminate daily
Thermometer: single-patient-use probe covers or dedicated thermometer
IV infusion pump: stays in room during admission — clean externally daily with approved wipes
Wound care trolley / equipment: all supplies taken into room are not returned to stock
Dispose or decontaminate ALL equipment before it leaves the room

Patient Transport During Isolation

Minimise patient transport — only for essential procedures
Notify receiving department in advance — allow preparation of contact precautions
Patient: clean gown, wound covered, urinary catheter bag sealed
Transport staff: gloves + gown for direct patient contact during transfer
Wheelchair / trolley: clean and disinfect before and after transport
Return patient via the most direct route — avoid high-traffic areas
Document every transport episode in nursing notes

MRSA Decolonisation Protocol

For confirmed MRSA-positive patients — 5-day decolonisation course. Requires physician order and infection control team involvement.

Component	Regimen	Duration / Notes
Body wash	4% Chlorhexidine gluconate (CHG) — whole body wash	Daily × 5 days — avoid eyes, ears, mucous membranes
Hair wash	Chlorhexidine shampoo	Daily × 5 days — hair is a reservoir
Nasal ointment	Mupirocin 2% (Bactroban) nasal ointment TDS (3× daily)	×5 days both nostrils — apply with cotton bud; avoid if MRSA mupirocin-resistant
Oral antiseptic	Chlorhexidine 0.2% mouthwash	Twice daily × 5 days — ventilated patients and those with oropharyngeal MRSA
Linen change	Full bed linen and pillow replacement	Daily during decolonisation period — bag and send as infectious linen
Follow-up screens	Repeat MRSA screen at 48h post-completion	3 negative screens (48h apart) required to clear isolation in most GCC protocols

⚠️ Clostridioides difficile Infection (CDI)

    Critical Alert: Alcohol-based hand gel does NOT kill C. difficile spores. Soap and water (mechanical removal) is MANDATORY for CDI patients.
  

Epidemiology & Pathophysiology

Gram-positive, anaerobic, spore-forming bacillus — spores survive on surfaces for months
Antibiotic-associated: disruption of normal bowel flora allows C. diff overgrowth — highest risk with clindamycin, fluoroquinolones, cephalosporins, carbapenem
Hospital-acquired CDI (HA-CDI): onset >48h after admission OR within 12 weeks of discharge
Community-acquired CDI increasing in GCC — linked to outpatient antibiotic overuse
Toxin A and Toxin B — mediate colonic mucosal damage, inflammation, and diarrhoea
Ribotype 027 (hypervirulent) — produces binary toxin, associated with higher mortality

CDI Diagnosis

Clinical criteria: unformed/loose stool (Bristol type 5–7) ≥3 episodes in 24h NOT explained by other causes
Do NOT test formed stool — high false-positive rate, test only diarrhoeal samples
Toxin EIA: rapid, specific but less sensitive — positive toxin confirms CDI
PCR (NAAT): highly sensitive — detects toxin gene; positive = CDI if clinical context appropriate
GDH (glutamate dehydrogenase): sensitive screening antigen — if positive, confirm with toxin EIA
Colonoscopy/histology: pseudomembranous colitis — for complex or severe cases

Severity Assessment

Severity	Criteria	Action
Mild	Diarrhoea only, WBC normal, creatinine normal	Oral vancomycin 125mg QDS × 10 days; review precipitating antibiotics
Moderate	WBC 11–15 × 10⁹/L, creatinine up to 1.5× baseline	Oral vancomycin 125mg QDS × 10 days; surgical review
Severe	WBC >15 × 10⁹/L AND/OR creatinine >1.5× baseline	Oral vancomycin 500mg QDS + IV metronidazole; surgical consult urgent
Fulminant	Hypotension, ileus, megacolon, peritonitis	IV metronidazole + rectal vancomycin ± colectomy — ICU transfer

Treatment — GCC Protocol

First episode (non-severe): oral vancomycin 125mg QDS × 10 days — preferred over metronidazole
First episode (severe): oral vancomycin 500mg QDS × 10 days
First recurrence: fidaxomicin 200mg BD × 10 days (superior to vancomycin for recurrence prevention)
Multiple recurrences: consider faecal microbiota transplantation (FMT) — available in select GCC centres
Bezlotoxumab (Zinplava): monoclonal antibody — IV infusion to prevent recurrence in high-risk patients
STOP precipitating antibiotics immediately if clinically safe to do so
Probiotics: not recommended during CDI treatment; Lactobacillus rhamnosus for prevention

Infection Control for CDI

Single room + en-suite toilet: mandatory — do not share bathrooms
Contact precautions: gloves AND apron for all patient contact
Hand hygiene: soap and water ONLY — alcohol gel ineffective against spores
Daily cleaning: 1,000 ppm sodium hypochlorite (0.1% bleach) — spores killed by chlorine
Terminal cleaning on discharge: 10,000 ppm (1%) sodium hypochlorite — all surfaces including bed frame, call bell, handles
Curtains: change on discharge — spores adhere to fabric
Duration of precautions: 48h after last episode of diarrhoea (some protocols: until discharge)

🚨 Outbreak Investigation & Control

Outbreak Definition

Definition: two or more cases of the same infection, linked in time and place, that exceed the expected background rate
A single case of a rare pathogen (e.g., CRAB in a previously clean ICU) may constitute a "pseudo-outbreak" requiring immediate investigation
Distinguish: sporadic HAI (individual case) vs. cluster vs. true outbreak
Alert: unusual organism, unusual resistance pattern, or higher than baseline rate = investigate immediately

Outbreak Investigation — Step-by-Step

Verify diagnosis: confirm microbiological identification and susceptibility results — lab quality check
Establish case definition: time (onset dates), place (ward/unit), person (patient demographics, risk factors)
Line listing: systematic table of all cases — date of admission, ward, organism, risk factors, outcomes — updated daily during outbreak
Calculate attack rates: number of cases / number exposed — identify high-risk groups
Hypothesis generation: review line listing for common exposures — shared procedures, staff, equipment, water source
Environmental sampling: culture surface swabs, water, shared equipment, air (if airborne suspected)
Molecular typing: PFGE/WGS to confirm clonal spread vs. polyclonal — confirms or refutes epidemiological link
Implement control measures: enhanced hand hygiene, cohorting, enhanced cleaning, antibiotic stewardship review
Case-control study: for larger outbreaks — identify exposure odds ratios to pinpoint source
Declare resolution: no new cases for ≥2 incubation periods + 2 weeks beyond last case

Outbreak Control Team (OCT) Members

Infection Control Nurse: surveillance, line listing, implementation of measures
Medical Microbiologist: laboratory support, organism typing, treatment guidance
Infectious Disease Physician: patient management, clinical decisions
Ward / Unit Manager: operational implementation — staffing, cleaning
Hospital Administration: resource allocation, media/public communication, regulatory notification
Pharmacy: antibiotic stewardship review during outbreak
Facilities/Housekeeping Manager: enhanced cleaning protocol implementation
Public Health Authority: DHA/MOH/regional authority notification if required

Enhanced Cleaning During Outbreak

Frequency: increase to at least twice daily for affected areas
Chlorine-releasing agents: 1,000 ppm for routine — 10,000 ppm for terminal clean
High-touch surfaces priority: door handles, bed rails, call bells, light switches, taps
Terminal clean: after each patient discharge from affected bay — document and sign-off
Curtain change: on each patient discharge during outbreak period
Post-clean environmental swabs: verify decontamination effectiveness
Fogging/hydrogen peroxide vapour: consider for high-burden outbreaks (e.g., CRAB)

Cohorting Outbreak Patients

Group all confirmed cases in a designated bay or unit — single area
Assign dedicated nursing staff to cohort — no cross-assignment to non-affected areas during that shift
Cohort staff wear PPE for all patient contact
Clear signage: "Outbreak Unit — Contact Precautions — Report to nurse before entering"
No new admissions to affected area until outbreak declared over

Communication During Outbreak

Staff communication: immediate briefing — what organism, what precautions, PPE required — written guidance issued
Patient communication: honest, reassuring, clear — explain isolation reasons and expected duration
Family communication: visitor restrictions explained, visiting protocols, hand hygiene instruction for visitors
Media: hospital administration and infection control lead — single spokesperson — factual, no speculation
Regulatory reporting: notify DHA/MOH/HAAD within required timeframe (usually 24–72h depending on pathogen)

📊 HAI Surveillance & Screening

NHSN/CDC Standard HAI Definitions

HAI Type	Definition (Summary)	Key Criteria
CLABSI	Central Line-Associated Bloodstream Infection	BSI not related to another site, with CVC in situ within 48h; onset >2 days after admission
CAUTI	Catheter-Associated UTI	Urinary catheter in place >2 days at onset; SUTI criteria (symptoms + positive culture ≥10⁵ CFU/mL)
VAP	Ventilator-Associated Pneumonia	Mechanical ventilation >2 days; new/worsening infiltrate + clinical criteria; VAE (Ventilator-Associated Events) replaces some VAP metrics
SSI	Surgical Site Infection	Within 30 days of surgery (90 days if implant); superficial/deep incisional or organ/space; 30-day post-discharge surveillance is the key challenge
CDI	C. difficile Infection	Positive toxin test + diarrhoea; HA-CDI onset >3 days after admission

GCC Note: NHSN definitions are widely adopted in UAE (DHA/HAAD) and Saudi Arabia (MOH). Use standard definitions only — do not modify locally to avoid benchmark comparability errors.

Point Prevalence Survey (WHO PPS)

WHO PPS methodology: one-day snapshot of all inpatients — captures active HAI and antibiotic use simultaneously
Survey day: select representative single day — capture all inpatients 08:00 hours that day
Data collected: patient demographics, underlying conditions, device use (CVC/catheter/ventilator), current antibiotic(s), HAI signs meeting case definition
Outputs: HAI prevalence rate + antibiotic use prevalence — benchmark across institutions
GCC hospitals increasingly adopting WHO PPS as annual quality indicator
WHO PPS tool freely available at: who.int/teams/integrated-health-services/patient-safety

Blood Culture Quality Metrics

Contamination rate target: <3% — higher rates indicate poor collection technique
Contaminants: coagulase-negative Staphylococci (CoNS), Bacillus spp., Propionibacterium — single bottle positivity
True bacteraemia: same organism in 2+ sets, or known pathogen in any set
Proper technique: chlorhexidine + alcohol skin prep, 30-60 second drying time, aseptic collection
Antibiogram report: local cumulative susceptibility data — hospital pharmacy/microbiology — used to guide empirical antibiotic prescribing without waiting for culture results
Review antibiogram annually — update empirical prescribing guidelines accordingly

Alert Organisms & Mandatory Reporting — GCC

Immediate Notification to IC Team:

CRE (any site) — same day notification
CRAB bacteraemia or sterile site
MRSA bacteraemia — same day
VRE — first case on any ward
CDI — positive toxin result
Any unusual resistance pattern (e.g., colistin-resistant Klebsiella)

Mandatory Reporting to Health Authority:

Dubai (DHA): reportable disease list — Circular IC 2024 — includes MRSA bacteraemia, CRE, CRAB outbreaks, TB, meningococcal disease
Abu Dhabi (HAAD/DOH): HAAD Health Information Exchange — mandatory electronic reporting
Saudi Arabia (MOH): Electronic disease surveillance system (Noor) — 33 notifiable conditions
Timelines: immediate (within 24h) for critical pathogens; weekly aggregate data for others

SSI Post-Discharge Surveillance — The Challenge

30-day post-discharge surveillance required per NHSN definitions — but most infections appear after discharge with shorter inpatient stays
Methods: telephone follow-up, patient-reported questionnaire, GP/clinic follow-up linking, readmission monitoring
Electronic health record alerts: flag readmissions with wound-related codes within 30 days of index surgery
Surgeon questionnaire: structured wound assessment at post-op clinic visit
Challenge in GCC: high patient mobility, many patients return to home countries — limits follow-up completeness

🌙 GCC-Specific Infection Control Context

Hajj Mass Gathering — Infection Control

Hajj: 2–3 million pilgrims from 180+ countries — largest annual mass gathering in the world. Creates unique infection transmission dynamics.

Meningococcal disease: Neisseria meningitidis ACWY vaccine — mandatory for all pilgrims — Saudi MOH requirement since 1988; proof required for Hajj visa
Respiratory illness: "Hajj cough" — high prevalence of acute respiratory infections; overcrowding, tent ventilation, dust
MERS-CoV surveillance: heightened surveillance during Hajj period; clinical case definition + contact tracing protocols

Water-borne disease: risk from communal water sources — Zamzam water safety, food safety monitoring
Heat-related illness: not infection but a major public health concern — overlaps with infection surveillance
International health regulations: WHO IHR 2005 — KSA reports Hajj-associated disease outbreaks to WHO
Saudi MOH deploys 25,000+ health workers during Hajj; field hospitals at Mina/Muzdalifah/Arafat

MERS-CoV in GCC

Epidemiology:

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) — betacoronavirus
Zoonotic reservoir: dromedary camels — seroprevalence 90%+ in adult camels in GCC
Human cases: Saudi Arabia (~80% of global cases), UAE, Jordan, Qatar — sporadic transmission from camels to humans
Human-to-human transmission: healthcare setting predominant (amplification outbreaks — South Korea 2015)
Case fatality rate ~35% — immunocompromised and comorbidity patients highest risk

Infection Control for MERS-CoV:

Standard + Contact + Airborne precautions (WHO: contact + droplet; WHO also recommends airborne for aerosol-generating procedures)
N95 respirator (fit-tested) for all direct patient care
Negative pressure room mandatory
PPE donning/doffing training — annual competency assessment for all ICU/ED staff in high-risk GCC hospitals
Suspected MERS: notify infection control immediately + public health authority
Contact tracing: all HCW exposures within 2 metres without PPE for >10 minutes

Healthcare Worker Immunisation — GCC Requirements

Hepatitis B: 3-dose series MANDATORY for HCW registration in DHA, DOH, Saudi MOH — anti-HBs titre >10 IU/L required as proof of immunity
Influenza: annual vaccination strongly recommended; DHA and DOH mandate for patient-facing staff
MMR (Measles/Mumps/Rubella): 2-dose history required — serological proof if uncertain
Varicella: history of disease or 2-dose vaccination — serology if unknown history
Tdap: recommended for staff in neonatal/paediatric areas
Meningococcal ACWY: recommended for staff working in Hajj healthcare services

TB Screening for HCW Registration

Mantoux (TST): tuberculin skin test — 5TU PPD intradermal; read at 48–72h; ≥10mm induration = positive in HCW
IGRA (Interferon Gamma Release Assay): QuantiFERON-TB Gold, T-SPOT.TB — preferred in BCG-vaccinated individuals (avoids false positives)
DHA registration: IGRA/Mantoux required; positive test → chest X-ray → refer to TB clinic if active disease excluded
Saudi MOH: chest X-ray + IGRA mandatory for all expatriate HCW registration; annual screening for high-risk areas
LTBI (latent TB): treat as per local protocol — isoniazid 9 months or rifampicin 4 months
High TB burden countries of origin in GCC workforce: Philippines, India, Egypt, Pakistan — higher baseline risk

GCC IC Nursing Certification & Regulatory Audits

CIC (Certification in Infection Control): CBIC examination — gold standard IC credential; growing demand for CIC among GCC nurses
APIC (Association for Professionals in Infection Control): membership increasing in GCC — UAE and KSA chapters active
GCC IC nurses often take CIC after 2+ years of IC practice — exam covers epidemiology, microbiology, cleaning/sterilisation, management
DHA and DOH require IC-designated nurses in all licensed facilities — CIC preferred qualification

HAAD/DOH IC Audit: annual requirement — structured inspection tool; categories: hand hygiene, environmental cleaning, PPE compliance, surveillance, policy documentation
DHA IC Audit: scored assessment — minimum pass mark; poor performers subject to follow-up inspection and corrective action plans
Saudi MOH: Central Board for Accreditation of Healthcare Institutions (CBAHI) — includes IC standards as core domain
JCI (Joint Commission International): accreditation widely sought in GCC — IPAC (Infection Prevention & Control) chapter is a major component

🔍 Interactive Isolation Precautions Guide

Select Organism or Condition

Precaution Type

PPE Required

Environmental Cleaning

Duration & Discontinuation

Patient & Family Communication Points